Fish and Richardson P.C.
Intellectual Property | Litigation

Practice Areas
Technology Areas
About Us
Firm Directory
Articles
work@fr.com
Diversity
Contact Us
Home
Search
FR


Mark S. Ellinger

photo
Office: Twin Cities
Phone: 612 337-2504
Email: ellinger@fr.com



Go Back to Attorney List

print View Printable Page
Practice areas
Patents
Venture and Technology
 
Technology areas
Nanotechnology
Life Sciences
Biology
Medical Devices
Genetics
 
Education
Augsburg College B.A. Biology 1971 magna cum laude
University of Minnesota Ph.D. Developmental Biology 1976
Harvard Law School J.D. 1989

Professional experience
Mark S. Ellinger is a Senior Principal in Fish & Richardson P.C.'s Twin Cities office. His practice emphasizes patent prosecution, opinions, due diligence investigations, licensing and counseling in the medical biotechnology, agricultural biotechnology, diagnostic, pharmaceutical, and medical science fields.

Dr. Ellinger's projects have involved subject matter such as genomics, proteomics, gene therapy, xenotransplantation, transgenic animals, transgenic plants, metabolic engineering, immunoassays, nucleic acid-based assays, antisense technology, nucleic acid analogues, microarrays, vaccines, stem cells, medical devices, food science, and potential treatments for diseases such as cardiovascular disease, cancer, allergy, arthritis, diabetes, and Alzheimer's Disease.

His litigation experience includes immunodiagnostics, cardiac assays, microsatellite DNA assays, plant genetics, and transgenic animals.

His licensing experience includes university/industry collaborations, patent outlicensing and inlicensing programs, and joint ventures.

Selected publications and presentations
Dr. Ellinger is the author of nineteen scientific publications. The following is a selection of his legal articles.

"DNA Diagnostic Technology: Probing the Problem of Causation in Toxic Torts," Harvard Journal of Law & Technology, 3, 31-73 (1990).

"Genome Projects And Gene Patents: What's Left To Claim?" Technology Law Alert, 27, 1-4 (December 2000).

"Patents And Post-Embryonic Stem Cells: Is There Anything New Under The Sun?" The Journal Of Life Sciences (May 2007).

"Patent Protection For Stem Cells In A Changing Scientific And Legal Environment" Burrill Stem Cell Report, 2, 121-124 (October 2007).

"Patent Protection For Combination Products In The USA" MedTech Business Review, 2, 48-53 (2007).

Co-author of treatise and lecturer for Patent Resources Group advanced course, "Biotechnology: Patent Prosecution, Licensing, Litigation, And Hatch-Waxman" (2000-present).

Bar admissions
Admitted to the bar in Minnesota.
Registered to practice before the United States Patent and Trademark Office.

Additional information
Assistant/Associate Professor (tenured), Southern Illinois University (1977-1986). Visiting Scientist, Virus and Cell Biology Research Department, Merck Sharp & Dohme Research Laboratories (1983-1984).

Listed in the 2007 and 2008 editions of Best Lawyers in America in Intellectual Property Law. Named as one of the "Top 40 Intellectual Property Attorneys," Minnesota Law & Politics, June/July 2009.